Wendy’s Surges in Premarket as Retail Traders Launch “Save Wendy’s” Meme Campaign
High short interest, new CFO appointment, and activist investor Trian fuel the rally.
Already have an account? Sign in.
High short interest, new CFO appointment, and activist investor Trian fuel the rally.
The FDA approved Scholar Rock’s Isembyld, the first SMA therapy aimed at muscle wasting in patients already on nerve-targeted treatment.
The Phase III SERENA-4 trial did not meet its primary PFS endpoint in untreated advanced ER-positive, HER2-negative breast cancer, despite a numerical benefit.
Citi added a 90-day upside view on AppLovin with a $600 target, calling Q3 concerns misguided.